We provide 1 form of Abametapir
Abametapir
1762-34-1
|
184.1
|
2.562
Abametapir is a novel pediculicidal metalloproteinase inhibitor. Abametapir is indicated, in the context of an overall lice management program, for the topical treatment of head lice infestation in patients 6 months of age and older.
4,4'-dimethyl-2,2'-bipyridyl | 5,5'-dimethyl-2,2'-bipyridine | 5,5'-dimethyl-2,2'-bipyridyl | 5,5'-dimethyl-2,2'-dipyridyl | 5,5’-dimethyl-2,2’-bipyridine | 5,5′-dimethyl-2,2′-dipyridyl | dmbpy
Abametapir is a novel pediculicidal metalloproteinase inhibitor. Abametapir is indicated, in the context of an overall lice management program, for the topical treatment of head lice infestation in patients 6 months of age and older.
4,4'-dimethyl-2,2'-bipyridyl | 5,5'-dimethyl-2,2'-bipyridine | 5,5'-dimethyl-2,2'-bipyridyl | 5,5'-dimethyl-2,2'-dipyridyl | 5,5’-dimethyl-2,2’-bipyridine | 5,5′-dimethyl-2,2′-dipyridyl | dmbpy
$19/5 mg
(EBC)
1
We provide 0 compound for Abametapir